About
Model
Values
People
Partners
Pipeline
Bioelesonic™
Nitric oxide
Plant lectins
Newsroom
News
Events
Investors
Contact
Newsroom
News
SynDermix Announces Interim Changes to Leadership
20 May, 2020
Update on the Clinical Trial of the SDX-3101 Medical Device
7 April, 2020
First Site Initiation Visit (SIV) Completed for the Clinical Trial of SDX-3101 in Austria
7 January, 2020
Collaboration with King’s College London on the Formulation Development of SDX-21
1 July, 2019
AGM 2019: Re-election of Chairman and Board of Directors
11 June, 2019
SynDermix to Sell Majority Stake of SDX-Cosmetics
10 April, 2019
SynDermix Announces Changes to the Executive Team
1 April, 2019
Share Capital Increased
14 March, 2019
CHF 10 Million Investment
19 December, 2018
SDX-3103 Kick-Off Meeting, Biel
25 October, 2018
Upcoming Events
2nd Annual European HealthTech CEO Forum
8-12 March, 2021
Digital RESI
15-17 March, 2021
Media
SynDermix fact-sheet